Cited by 282Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major DepressionPsychological Testing and Assessment

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)

Müller, M·2003·Journal of Affective Disorders

DOI 10.1016/s0165-0327(02)00120-9

Open this paper in CoChat — free account

Abstract

Background MADRS cut-off scores for moderate and severe depression were estimated in relation to the Hamilton Depression Rating Scale (HAMD(17)) and the Clinical Global Impressions Scale (CGI).Method HAMD(17), MADRS, and CGI ratings from patients with major depression (DSM-IV) were analyzed (N=85). Receiver operating characteristics (ROC) curves were applied.Results Mean age was 51.4+/-14.5 years, 69% were female. Mean MADRS scores were 23.4+/-13.2, HAMD(17), MADRS, and CGI scores were highly correlated (r>0.85; P<0.0001). Best separation between moderate and severe depression according to CGI criteria was achieved with a MADRS score of 31 (sensitivity 93.5%, specificity 83.3%).Limitations Studies to validate severity gradations including DSM-IV or ICD-10 diagnostic severity categories are recommended.Conclusions Empirically based MADRS cut-off scores to separate moderate from severe depression on the basis of HAMD(17) and CGI severity ratings in patients with major depression were yielded.

Integrity signals

Registry

Crossref · 10.1016/s0165-0327(02)00120-9

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Grade Scores of the Montgomery—Åsberg Depression and the Clinical Anxiety Scales
Snaith, R. P., Harrop, F. M., Newby, D. A., & Teale, C. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.148.5.599 · Cited by 365
A Comparison of Depression Rating Scales
Kearns, N. P., Cruickshank, C. A., McGuigan, K. J., Riley, S., Shaw, S. P., & Snaith, R. P. (1982) · The British Journal of Psychiatry · doi:10.1192/bjp.141.1.45 · Cited by 273
Exactly what does the Hamilton depression rating scale measure?
Gibbons, R. D., Clark, D. C., & Kupfer, D. J. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90037-3 · Cited by 223
St John's Wort for depression
Linde, K., & Mulrow, C. D. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000448 · Cited by 179
What Do Depression Rating Scales Measure?
Snaith, P. R. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.3.293 · Cited by 166
Efficacy of SSRIs and Newer Antidepressants in Severe Depression
Hirschfeld, R. M. A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0511 · Cited by 152
Comparative analysis of observer depression scales
Maier, W., & Philipp, M. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02601.x · Cited by 136
Moderate and severe depression
Müller, M. J., Szegedi, A., Wetzel, H., & Benkert, O. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00162-7 · Cited by 116
Self-citation

Show all 22 references

Sorted by citations

Severity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 909
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression: A Double-blind, Placebo-controlled Study (The BOLDER II Study)
Thase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559
A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression
Romijn, A. R., Rucklidge, J. J., Kuijer, R. G., & Frampton, C. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416686694 · Cited by 323
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R. C., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 314
The burden of severe depression: A review of diagnostic challenges and treatment alternatives
Nemeroff, C. B. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.008 · Cited by 301
Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.007 · Cited by 229
Post-stroke depression
Gaete, J., & Bogousslavsky, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.1.75 · Cited by 425
Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression
Li, Z., Lai, J., Zhang, P., Ding, J., Jiang, J., Liu, C., Huang, H., Zhen, H., Xi, C., Sun, Y., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01569-9 · Cited by 227
Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial.
Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0028208 · Cited by 221
Fluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114.pub2 · Cited by 213
Social cognition and emotional assessment differentiates frontotemporal dementia from depression
Bertoux, M., Delavest, M., de Souza, L. C., Funkiewiez, A., Lépine, J.-P., Fossati, P., Dubois, B., & Sarazin, M. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301849 · Cited by 204
Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms
Váradi, C. (2020) · Biology · doi:10.3390/biology9050103 · Cited by 196
Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: A randomised controlled trial
Veale, D., Anson, M., Miles, S., Pieta, M., Costa, A., & Ellison, N. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000360740 · Cited by 179
Randomised controlled trial of interpersonal psychotherapy and cognitive–behavioural therapy for depression
Luty, S. E., Carter, J. D., McKenzie, J. M., Rae, A. M., FRAMPTON, C. M. A., Mulder, R., & Joyce, P. R. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.024729 · Cited by 183
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
Goodwin, G. M., Croal, M., Feifel, D., Kelly, J. R., Marwood, L., Mistry, S., O’Keane, V., Peck, S. K., Simmons, H., Sisa, C., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01648-7 · Cited by 187
Rating Scales for Depression
Cusin, C., Yang, H., Yeung, A., & D, M. F. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-387-5_2 · Cited by 176
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 172
The clinical effectiveness, cost-effectiveness and acceptability of community-based interventions aimed at improving or maintaining quality of life in children of parents with serious mental illness: a systematic review
Bee, P., Bower, P., Byford, S., Churchill, R. C., Calam, R. M., Stallard, P. N., Pryjmachuk, S., Berzins, K. M., Cary, M., Wan, M. W., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18080 · Cited by 172
Ketamine and other glutamate receptor modulators for depression in adults
Caddy, C., Amit, B. H., McCloud, T. L., Rendell, J. M., Furukawa, T. A., McShane, R., Hawton, K., & Cipriani, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011612.pub2 · Cited by 174
Rumination, distraction, and mindful self-focus in depressed patients
Huffziger, S., & Kuehner, C. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2008.12.005 · Cited by 157
Determinants of subjective quality of life in depressed patients: The role of self-esteem, response styles, and social support
Kuehner, C., & Buerger, C. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.01.014 · Cited by 145
The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder
Arbuckle, R. A., Frye, M. A., Brecher, M., Paulsson, B., Rajagopalan, K., Palmer, S., & Innocenti, A. D. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.018 · Cited by 152
Molecular biomarkers of depression
Gururajan, A., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.011 · Cited by 141
Explanatory Models and Help-Seeking Behavior: Pathways to Psychiatric Care Among Patients Admitted for Depression in Mulago Hospital, Kampala, Uganda
Okello, E. S., & Neema, S. (2006) · Qualitative Health Research · doi:10.1177/1049732306296433 · Cited by 130
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression.
Hengartner, M. P., & Plöderl, M. (2022) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111600 · Cited by 114
Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
Wolfsgruber, S., Polcher, A., Koppara, A., Kleineidam, L., Frölich, L., Peters, O., Hüll, M., Rüther, E., Wiltfang, J., Maier, W., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161252 · Cited by 114
Depresjon
Garcia-Ceja, E., Riegler, M. A., Jakobsen, P., Tørresen, J., Nordgreen, T., Oedegaard, K. J., & Fasmer, O. B. (2018) · ACM Multimedia Systems Conference (MMSys) · doi:10.1145/3204949.3208125 · Cited by 123
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial
Calabrese, J. R., Durgam, S., Satlin, A., Vanover, K. E., Davis, R. E., Chen, R., Kozauer, S. G., Mates, S. L., & Sachs, G. S. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.20091339 · Cited by 113
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
Boulenger, J.-P., Huusom, A. K. T., Florea, I., Bækdal, T. A., & Sarchiapone, M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x115513 · Cited by 112
Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder.
Harkness, K. L., Bagby, R. M., & Kennedy, S. H. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0027665 · Cited by 116
Repetitive transcranial magnetic stimulation with resting-state network targeting for treatment-resistant depression in traumatic brain injury: a randomized, controlled, double-blinded pilot study
Siddiqi, S. H., Trapp, N. T., Hacker, C. D., Laumann, T. O., Kandala, S., Hong, X., Trillo, L., Shahim, P., Leuthardt, E. C., Carter, A. R., et al. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.5889 · Cited by 106
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults
McCloud, T. L., Caddy, C., Jochim, J., Rendell, J. M., Diamond, P. R., Shuttleworth, C., Brett, D., Amit, B. H., McShane, R., Hamadi, L., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011611.pub2 · Cited by 102
Agomelatine versus other antidepressive agents for major depression
Guaiana, G., Gupta, S., Chiodo, D., Davies, S., Haederle, K., & Koesters, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008851.pub2 · Cited by 107
Lack of exposure to natural light in the workspace is associated with physiological, sleep and depressive symptoms
Corrêa, F. H., Hidalgo, M. P. L., & Martau, B. T. (2014) · Chronobiology International · doi:10.3109/07420528.2014.982757 · Cited by 95
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
Dean, R. L., Hurducas, C., Hawton, K., Spyridi, S., Cowen, P. J., Hollingsworth, S., Marquardt, T., Barnes, A., Smith, R., McShane, R., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011612.pub3 · Cited by 95
Clinical practice recommendations for depression
Malhi, G. S., Adams, D., Porter, R., Wignall, A., Lampe, L. A., O’Connor, N., Paton, M. B., Newton, L., Walter, G., Taylor, A., et al. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01382.x · Cited by 95
The differential associations of depression and diabetes distress with quality of life domains in type 2 diabetes
Carper, M. M., Traeger, L. N., Gonzalez, J. S., Wexler, D. J., Psaros, C., & Safren, S. A. (2013) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9505-x · Cited by 99
Hamilton depression rating scale and montgomery–asberg depression rating scale in depressed and bipolar I patients: psychometric properties in a Brazilian sample
Carneiro, A. M., Fernandes, F. D. S., & Moreno, R. A. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0235-3 · Cited by 88
Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials
Chawla, N., Anothaisintawee, T., Charoenrungrueangchai, K., Thaipisuttikul, P., McKay, G. J., Attia, J., & Thakkinstian, A. (2022) · BMJ · doi:10.1136/bmj-2021-066084 · Cited by 96
Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study)
Calkin, C. V., Chengappa, K. N. R., Cairns, K., Cookey, J., Gannon, J., Alda, M., O’Donovan, C., Reardon, C., Sanches, M., & Růzicková, M. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.21m14022 · Cited by 85
Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial
Comasco, E., Kallner, H. K., Bixo, M., Hirschberg, A. L., Nyback, S., de Grauw, H., Epperson, C. N., & Poromaa, I. S. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20030286 · Cited by 81
Magnesium–ibogaine therapy in veterans with traumatic brain injuries
Cherian, K. N., Keynan, J. N., Anker, L. A., Faerman, A., Brown, R. E., Shamma, A., Keynan, O., Coetzee, J. P., Batail, J.-M. V., Phillips, A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02705-w · Cited by 80
The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression
Carter, J. D., FRAMPTON, C. M. A., Mulder, R., Luty, S. E., & Joyce, P. R. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.11.011 · Cited by 78
Tangled Up in Blue: Unraveling the Links Between Emotional Distress and Treatment Adherence in Type 2 Diabetes
Gonzalez, J. S., Kane, N. S., Binko, D. H., Shapira, A., & Hoogendoorn, C. J. (2016) · Diabetes Care · doi:10.2337/dc16-1657 · Cited by 80
Depression in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): The Mediating Role of Cognitive-Behavioral Factors
Knouse, L. E., Zvorsky, I., & Safren, S. A. (2013) · Cognitive Therapy and Research · doi:10.1007/s10608-013-9569-5 · Cited by 78
A longitudinal study of rumination and distraction in formerly depressed inpatients and community controls.
Huffziger, S., Reinhard, I., & Kuehner, C. (2009) · Journal of Abnormal Psychology · doi:10.1037/a0016946 · Cited by 80
Cognitive behavioral therapy for body image and self-care (CBT-BISC) in sexual minority men living with HIV: A randomized controlled trial.
Blashill, A. J., Safren, S. A., Wilhelm, S., Jampel, J. D., Taylor, S. W., O’Cleirigh, C. M., & Mayer, K. H. (2017) · Health Psychology · doi:10.1037/hea0000505 · Cited by 75
LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY
Ketter, T. A., Sarma, K., Silva, R., Kroger, H., Cucchiaro, J. B., & Loebel, A. D. (2016) · Depression and Anxiety · doi:10.1002/da.22479 · Cited by 69
High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder
Lu, Y.-R., Rao, Y., Mou, Y.-J., Chen, Y., Lou, H., Zhang, Y., Zhang, D.-X., Xie, H., Hu, L., & Fang, P. (2019) · Medicine · doi:10.1097/md.0000000000014419 · Cited by 74
Escitalopram for the Prevention of Peginterferon-α2a–Associated Depression in Hepatitis C Virus–Infected Patients Without Previous Psychiatric Disease
Schaefer, M., Sarkar, R., Knop, V., Effenberger, S., Friebe, A., Heinze, L., Spengler, U., Schlaepfer, T. E., Reimer, J., Buggisch, P., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00006 · Cited by 68
Hypericum extract LI 160 and fluoxetine in mild to moderate depression
Bjerkenstedt, L., Edman, G., Alken, R. G., & Mannel, M. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0532-z · Cited by 68
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
Fornaro, M., McCarthy, M. J., De Berardis, D., Pasquale, D., Martino, Colicchio, Cattaneo, D'Angelo, Fornaro, P., & Tabaton (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41557 · Cited by 67
Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
Wolfsgruber, S., Jessen, F., Koppara, A., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H. J., Heuser, I., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001399 · Cited by 63
The Effect of Sertraline Add-On to Brief Dynamic Psychotherapy for the Treatment of Postpartum Depression
Bloch, M., Meiboom, H., Lorberblat, M., Bluvstein, I., Aharonov, I., & Schreiber, S. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07117 · Cited by 63
Reference values for major depression questionnaires: The Leiden Routine Outcome Monitoring Study
Schulte-van Maaren, Y. W. M., Carlier, I. V. E., Zitman, F. G., van Hemert, A. M., de Waal, M. W. M., van der Does, A. J. W., van Noorden, M. S., & Giltay, E. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.009 · Cited by 62
Can psychomotor disturbance predict ect outcome in depression?
van Diermen, L., Vanmarcke, S., Walther, S., Moens, H., Veltman, E. M., Fransén, E., Sabbe, B., van der Mast, R. C., Birkenhäger, T. K., & Schrijvers, D. L. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.07.009 · Cited by 61
Bouldering psychotherapy is more effective in the treatment of depression than physical exercise alone: results of a multicentre randomised controlled intervention study
Karg‐Hefner, N., Dorscht, L., Kornhuber, J., & Luttenberger, K. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02518-y · Cited by 61
The Assessment of Poststroke Depression
Salter, K. L., Bhogal, S. K., Foley, N. C., Jutai, J. W., & Teasell, R. W. (2007) · Topics in Stroke Rehabilitation · doi:10.1310/tsr1403-1 · Cited by 58
Relative sensitivity of the Montgomery?????sberg depression rating scale, the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis
Khan, A., Brodhead, A. E., & Kolts, R. L. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00006 · Cited by 58
Homeopathic Individualized Q‐Potencies versus Fluoxetine for Moderate to Severe Depression: Double‐Blind, Randomized Non‐Inferiority Trial
Adler, U. C., Paiva, N. M. P., César, A., Adler, M. S., Molina, A., Padula, A. E. M., & Calil, H. M. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep114 · Cited by 56
Treating co‐occurring first‐episode psychosis and borderline personality: a pilot randomized controlled trial
Gleeson, J. F. M., Chanen, A., Cotton, S. M., Pearce, T., Newman, B., & McCutcheon, L. (2012) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00306.x · Cited by 46
Age-associated decrease in global DNA methylation in patients with major depression
Lin, P., Tseng, P., Lee, Y. Z., Hung, C., Lung, F., Chen, C., & Chong, M. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s71997 · Cited by 45
Albumin and depression in elderly stroke survivors: An observational cohort study
Pascoe, M. C., Skoog, I. G., Blomstrand, C., & Linden, T. K. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.10.023 · Cited by 46
Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study
Shinto, L. H., Marracci, G., Mohr, D. C., Bumgarner, L., Murchison, C., Senders, A., & BOURDETTE, D. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147195 · Cited by 47
Motor Activity Based Classification of Depression in Unipolar and Bipolar Patients
Garcia-Ceja, E., Riegler, M. A., Jakobsen, P., Tørresen, J., Nordgreen, T., Oedegaard, K. J., & Fasmer, O. B. (2018) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2018.00062 · Cited by 47
A multistage chronobiologic intervention for the treatment of depression: A pilot study
Moscovici, L., & Kotler, M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.015 · Cited by 47
The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses
McIntyre, R. S., Durgam, S., Kozauer, S. G., Chen, R., Huo, J., Davis, R. E., & Cutler, A. J. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.12.012 · Cited by 48
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial
Conway, C. R., Aaronson, S. T., Sackeïm, H. A., George, M. S., Zajecka, J., Bunker, M. T., Duffy, W. J., Stedman, M., Riva‐Posse, P., Allen, R. M., et al. (2024) · Brain stimulation · doi:10.1016/j.brs.2024.12.1191 · Cited by 47
Biomarkers Predicting Treatment Outcome in Depression: What is Clinically Significant?
Uher, R., Tansey, K. E., Malki, K., & Perlis, R. H. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.161 · Cited by 44
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Dean, R. L., Marquardt, T., Hurducas, C., Spyridi, S., Barnes, A., Smith, R. P., Cowen, P. J., McShane, R. H., Hawton, K. E., Malhi, G. S., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011611.pub3 · Cited by 43
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium
Demyttenaere, K., Hemels, M. E. H., Hudry, J., & Annemans, L. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.001 · Cited by 43
Gender differences in clinical characteristics in a naturalistic sample of depressive outpatients: The Leiden Routine Outcome Monitoring Study
van Noorden, M. S., Giltay, E. J., den Hollander-Gijsman, M. E., van der Wee, N. J. A., van Veen, T., & Zitman, F. G. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.007 · Cited by 45
A Pilot Randomised Double-Blind Study of the Tolerability and efficacy of repetitive Transcranial Magnetic Stimulation on Persistent Post-Concussion Syndrome
Moussavi, Z., Suleiman, A., Rutherford, G., Pouya, O. R., Dastgheib, Z. A., Zhang, W., Salter, J. E., Wang, X., Mansouri, B., & Lithgow, B. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41923-6 · Cited by 48
Ketamine and other glutamate receptor modulators for depression in adults
Amit, B. H., Caddy, C., McCloud, T. L., Rendell, J. M., Hawton, K. E., Diamond, P. R., McShane, R. H., & Cipriani, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011612 · Cited by 44
Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient
Sheehan, D. V., Harnett-Sheehan, K., Hidalgo, R. B., Janavs, J., McElroy, S. L., Amado, D., & Suppes, T. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.016 · Cited by 42
Screening for depressive symptoms in patients with unresectable lung cancer
Néron, S., Correa, J. A., Dajczman, E., Kasymjanova, G., Kreisman, H., & Small, D. I. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0225-z · Cited by 43
Disruptions in segregation mechanisms in fMRI-based brain functional network predict the major depressive disorder condition
Khorev, V. S., Kurkin, S., Zlateva, G., Paunova, R., Kandilarova, S., Maes, M. H. J., Stoyanov, D., & Hramov, A. E. (2024) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2024.115566 · Cited by 40
Unmet needs of outpatients with late-life depression; a comparison of patient, staff and carer perceptions
Houtjes, W., van Meijel, B., Deeg, D. J. H., & Beekman, A. T. F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.052 · Cited by 39
Bouldering psychotherapy is not inferior to cognitive behavioural therapy in the group treatment of depression: A randomized controlled trial
Luttenberger, K., Karg‐Hefner, N., Berking, M., Kind, L., Weiss, M., Kornhuber, J., & Dorscht, L. (2021) · British Journal of Clinical Psychology · doi:10.1111/bjc.12347 · Cited by 36
Depression in lung cancer patients: is the HADS an effective screening tool?
Castelli, L., Binaschi, L., Caldera, P., & Torta, R. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0604-8 · Cited by 36
Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression
Garcia, F. D., Coquerel, Q., Kiive, E., Déchelotte, P., Harro, J., & Fetissov, S. O. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.021 · Cited by 34
Bouldering psychotherapy is effective in enhancing perceived self-efficacy in people with depression: results from a multicenter randomized controlled trial
Kratzer, A., Luttenberger, K., Karg‐Hefner, N., Weiss, M., & Dorscht, L. (2021) · BMC Psychology · doi:10.1186/s40359-021-00627-1 · Cited by 33
Detection of Depression in Acute Schizophrenia: Sensitivity and Specificity of 2 Standard Observer Rating Scales
Müller, M. J., Müller, K.-M., & Fellgiebel, A. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100609 · Cited by 33
Self-citation
Lower midbrain dopamine transporter availability in depressed patients: Report from high-resolution PET imaging
Dubol, M., Trichard, C., Leroy, C., Granger, B., Tzavara, E. T., Martinot, J., & Eric Artiges, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.041 · Cited by 33
Prevalence of Smartphone Addiction in Patients with Depression and Its Association with Depression Severity: a Cross-sectional Study
Lim, P. K., Nordin, A. S. A., Yee, A. H. A., & Tan, S. B. (2020) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-019-00203-0 · Cited by 33
Beyond Pairwise Interactions: Higher-Order Q-Analysis of fMRI-Based Brain Functional Networks in Patients With Major Depressive Disorder
Kurkin, S., Smirnov, N. M., Paunova, R., Kandilarova, S., Stoyanov, D., Mayorova, L. A., & Hramov, A. E. (2024) · IEEE Access · doi:10.1109/access.2024.3521249 · Cited by 31
Cognitive complaints and predictors of perceived cognitive dysfunction in adults with major depressive disorder: Findings from the Cognitive Dysfunction in Asians with Depression (CogDAD) study
Srisurapanont, M., Mok, Y. M., Yang, Y. K., Chan, H., Della, C. D., Zainal, N. Z., Jambunathan, S. T., Amir, N., & Kalita, P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.014 · Cited by 32
A German climbing study on depression: a bouldering psychotherapeutic group intervention in outpatients compared with state-of-the-art cognitive behavioural group therapy and physical activation – study protocol for a multicentre randomised controlled trial
Dorscht, L., Karg‐Hefner, N., Book, S., Graessel, E., Kornhuber, J., & Luttenberger, K. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2140-5 · Cited by 31
Physical Versus Virtual Reality–Based Calm Rooms for Psychiatric Inpatients: Quasi-Randomized Trial
Ilioudi, M., Lindner, P., Ali, L., Wallström, S., Thunström, A. O., Ioannou, M., Anving, N., Johansson, V., Hamilton, W., Falk, Ö., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/42365 · Cited by 29
Adjunctive lumateperone ( ITI ‐007) in the treatment of bipolar depression: Results from a randomized placebo‐controlled clinical trial
Suppes, T. M., Durgam, S., Kozauer, S. G., Chen, R., Lakkis, H. D., Davis, R. E., Satlin, A., Vanover, K. E., Mates, S. L., McIntyre, R. S., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13310 · Cited by 32
Effect of Aerobic Exercise Training on Chinese Population with Mild to Moderate Depression in Hong Kong
Ho, C. W. H., Chan, S. C. C., Wong, J. S., Cheung, W.-H., Chung, D. W. S., & Lau, T. F. O. (2014) · Rehabilitation Research and Practice · doi:10.1155/2014/627376 · Cited by 30
Evaluation of MADRS severity thresholds in patients with bipolar depression
Thase, M. E., Harrington, A., Calabrese, J. R., Montgomery, S., Niu, X., & Patel, M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.043 · Cited by 29
Pre-adult versus adult onset major depressive disorder in a naturalistic patient sample: the Leiden Routine Outcome Monitoring Study
van Noorden, M. S., Minkenberg, S. E., Giltay, E. J., den Hollander-Gijsman, M. E., van Rood, Y. R., van der Wee, N. J., & Zitman, F. G. (2010) · Psychological Medicine · doi:10.1017/s0033291710002199 · Cited by 28
Depressive symptoms and healthcare utilization in patients with noncardiac chest pain compared to patients with ischemic heart disease
Mourad, G., Jaarsma, T., Hallert, C., & Strömberg, A. (2012) · Heart & Lung · doi:10.1016/j.hrtlng.2012.04.002 · Cited by 28
Quetiapine monotherapy for bipolar depression
Thase, M. E. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1162 · Cited by 27
Clinical relevance of depressive symptom improvement in bipolar I depressed patients
Williamson, D. J., Brown, E., Perlis, R. H., AHL, J. S. B., Baker, R. W., & Tohen, M. F. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.011 · Cited by 28

Authors: Müller, M.
Affiliations: Johannes Gutenberg University Mainz (DE)
Corresponding author: Müller, M
ORCID: Müller, M
Venue: Journal of Affective Disorders
Publisher: Elsevier BV
Published: 2003-12
Volume: 77
Issue: 3
Pages: 255-260
ISSN: 0165-0327 (ISSN-L)
DOI: 10.1016/s0165-0327(02)00120-9
OpenAlex: W1979534890
Cited by: 282
References: 22
Citations by year: 2026: 18 · 2025: 26 · 2024: 30 · 2023: 23 · 2022: 15 · 2021: 20 · 2020: 11 · 2019: 12 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 14 · 2014: 12 · 2013: 9 · 2012: 16
FWCI: 3.36
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Affective Disorders (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: Montgomery-Asberg Depression Rating Scale, depression severity, moderate depression, severe depression, cut-off values, Hamilton Depression Rating Scale, Clinical Global Impression Scale, major depressive disorder, sensitivity and specificity
MeSH terms: Adult, Aged, Depressive Disorder, Diagnosis, Differential, Female, Humans, Male, Mental Status Schedule, Middle Aged, Reference Values, Severity of Illness Index, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks